Lung Cancer Program FAQs
What is the Sequoia Hospital Lung Cancer program?
The Sequoia Hospital Lung Cancer Program, in a unique collaboration with physicians from the University of California, San Francisco (UCSF) Medical Center, offers Bay Area lung cancer patients a comprehensive, dedicated multidisciplinary approach to lung cancer treatment. The Lung Cancer Program offers a wide range of services dedicated to the treatment of lung cancer, including early detection, tumor board, advanced surgical techniques, chemotherapy and radiation therapy. A team of physicians including pulmonologists, medical oncologists, radiation oncologists, and general surgeons collaborate to provide this comprehensive lung cancer treatment. Most patients have surgery, recover and receive their day-to-day care at Sequoia.
Patients with very complex cases are offered access to the world-renowned University of California, San Francisco (UCSF) Medical Center Thoracic Oncology Program and are seen by Dr. David Jablons, chief of general thoracic surgery. Dr. Jablons also evaluates, consults, and performs surgery at Sequoia Hospital.
Sequoia’s Lung Cancer program is overseen by a dedicated program coordinator who provides individual patient education and support.
Do I have to go to San Francisco?
No, the collaboration between Sequoia and UCSF allows patients to be evaluated and treated at Sequoia Hospital by physicians in conjunction with the chief of general thoracic surgery at UCSF, who sees patients and consults with the lung cancer team members. The vast majority of our patients receive all of their treatment right here at Sequoia Hospital.
What is Sequoia’s Early Detection Lung Cancer program about?
Sequoia’s Lung Cancer Early Detection Program is a participating member of the International Early Lung Cancer Action Program (I-ELCAP), administered originally by the Weill Cornell College of Medicine (now the Arizona Biodesign Institute and Mt. Sinai School of Medicine). I-ELCAP is designed specifically for lung cancer screening in patients who do not have symptoms but may meet other qualifying criteria. Patients are age 40 and over, typically with a history of smoking at least a 100 cigarettes in a lifetime. Patients who do not qualify for I-ELCAP, or do not want to participate in the trial, will be referred to lung cancer specialists for a consult. This clinical pathway reflects Sequoia’s unique, comprehensive approach to lung cancer diagnosis and treatment.
Sequoia is one of 50 institutions worldwide participating in I-ELCAP, the first research study of its kind evaluating the effectiveness of screening for lung cancer with low-dose CT scanning. In addition to revealing the condition of the lungs, the results include the Coronary Artery Calcification score - a marker of heart health. Scans are not free. The cost of a low-dose CT scan is $399, a significantly reduced rate.
Who should be evaluated in the lung cancer program?
People at risk for the development of lung cancer and those currently or previously diagnosed with lung cancer.
Who should be screened for lung cancer?
Our early detection program includes people age 40 and over, typically with a history of smoking or second hand smoke exposure.
How do I get started?
To learn more about the Lung Cancer Program, please call the program coordinator, Mirella Massad, at (650) 367-LUNG (5864).
Who can help me?
There are free services to help you quit smoking. Please contact Breathe California at (650) 994-1903 or 1-800-QUIT-NOW.